Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 73 results found. Search for [ anti-cancer drugs ]

Results 1 to 21 of 73
E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


BusinessToday.In
New Delhi, May 17, 2019
In March, the rates were brought down for around 380 drugs, with some cuts going to as much as 80-90 per cent under trade margin rationalisation.


Joe C Mathew
April 1, 2019
AIDAN complaints that the selection of 42 anti-cancer medicines was arbitrary as there are many equally high-priced anti-cancer drugs whose prices remain unaffordable and need to be curtailed


PTI
March 29, 2019



PTI
February 27, 2019



PTI
February 27, 2019



PTI
January 27, 2019



PTI
November 2, 2018



E Kumar Sharma
New Delhi, July 18, 2018
Those within the pharma industry see a couple of messages coming across from the movie.


BusinessToday.in
New Delhi, July 10, 2018
China agrees to cut tariffs on Indian cancer drugsChina said on Monday it had reached an agreement with India to reduce tariffs and increase imports of Indian medicines, particularly anti-cancer drugs. The decision was part of its efforts to broaden trade relations amid its on-going spat with the United States. Both India and China slashed import tariffs of a range of products starting July 1, following the fourth round of negotiations under the Asia Pacific Trade Agreement (APT...


Ananth Krishnan
July 10, 2018
India has particularly pressed China to open up its market for pharmaceuticals. There is widespread demand in China for Indian anticancer drugs which are often one-tenth the cost of the Western drugs that are available in China.


E Kumar Sharma
New Delhi, June 8, 2018
The Indian pharma has recently seen a perceptible slide in the number of new products hitting the market. According to the analysts, slippages are more in select therapies and they attribute this to several reasons.


PTI
April 4, 2018



E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.


Joe C Mathew
New Delhi, December 11, 2017
India is importing less pharmaceutical raw materials from China, but the Chinese challenge is far from over.


E Kumar Sharma
New Delhi, September 15, 2017
India has taken a lead here and going by the official figures, there are around 24 cancer biosimilar drugs in all that have already been approved by the Indian regulator since 2011.


PB Jayakumar
New Delhi, August 31, 2017
The company which started its Indian operations in 2004 is going to launch some of its latest epilepsy and cancer drugs in India.


Anand Kumar Patel
July 14, 2017
For instance, Emcure Pharmaceuticals was offering its drug Temcure 250 mg to an Amritsar-based cancer hospital at just Rs 1,950 while  patients have to pay about nine times more at  Rs 18,647.


Mail Today Bureau
New Delhi, June 28, 2017
Ahead of the GST rollout on July 1, the National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices of 761 medicines which includes a list of antibiotics and drugs for treating cancer, HIV, diabetes.


BT Online
New Delhi, August 17, 2016
Shares of Piramal Enterprises spiked 4 per cent to hit record high in trade on Wednesday after the company said it is set to acquire US-based contract development and manufacturing firm Ash Stevens Inc for over Rs 350 crore.


PAGES 1 OF 4  1234